glp 1 drug How long should you take GLP-1 drugs? Study links longer use to lower heart risk How GLP-1 medications are transforming

Int J Clin Pharm

The share who report ever taking these drugs rises to four in ten (43%) among adults who have been told by a doctor that they have diabetes, a quarter who have been told they have heart disease, and one in five (22%) who have been told by a doctor that they are overweight or obese in the past five years 1

In type 2 diabetes patients, it reduces HbA1c by approximately 2.1 percentage points and lowers body weight by an average of 6.2 kg

Zepbound Indications Zepbound (tirzepatide) is an injectable prescription medicine that may help adults with: obesity, or some adults with overweight who also have weight-related medical problems to lose excess body weight and keep the weight off

Tang and colleagues divided the participants into three comparison cohorts: GLP-1 receptor agonist (n = 10,212) vs